EX-23.1 3 ex_321308.htm EXHIBIT 23.1 ex_321308.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

 

We consent to the incorporation by reference in the Registration Statements (No. 333-234235, No. 333-252078, No. 333-252903, No. 333-257433, No. 333-257661 and No. 333-250945) on Form S-3 and Registration Statements (No. 333-203703, No. 333-210369, No. 333-216858, No. 333-224062, No. 333-230041, No. 333-236794, No. 333-252743 and No. 333-257429) on Form S-8 of KemPharm, Inc. of our report dated March 30, 2022 relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2021.

 

 

/s/ RSM US LLP

 

Orlando, Florida

March 30, 2022